01—History
Free Cash Flow History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2021–FY2026. Drag across the bars to change the range.
- $1.65B
YoY changeLargest recent move+165.2%in FY23Latest −0.7%
1 older move runs past ±150% (largest +165.2%); point at, tap or drag across the bars to read one.
02—Ledger
Free Cash Flow, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2026 | $1.65B | −0.7% | 10-K | |
| FY2025 | $1.66B | +27.6% | 10-K | |
| FY2024 | $1.30B | +126.9% | 10-K | |
| FY2023 | $573.6M | +165.2% | 10-K | |
| FY2022 | $216.3M | −65.9% | 10-K | |
| FY2021 | $634.0M | −10.3% | 10-K | |
| FY2020 | $706.9M | +81.1% | 10-K | |
| FY2019 | $390.3M | −11.8% | 10-K | |
| FY2018 | $442.4M | +25.8% | 10-K | |
| FY2017 | $351.8M | −28.1% | 10-K | |
| FY2016 | $489.4M | +52.6% | 10-K | |
| FY2015 | $320.7M | +0.7% | 10-K | |
| FY2014 | $318.5M | −6.1% | 10-K | |
| FY2013 | $339.2M | +1.0% | 10-K | |
| FY2012 | $336.0M | +55.1% | 10-K | |
| FY2011 | $216.6M | +64.9% | 10-K | |
| FY2010 | $131.4M | +1.7% | 10-K | |
| FY2009 | $129.2M | — | 10-K |
03—Questions
What is ResMed's current free cash flow?
ResMed (RMD) annual free cash flow for 2026 was $1.65B, a 0.73% decline from 2025. ResMed free cash flow for the quarter ending September 30, 2026 was $373.7M.
What was ResMed's free cash flow in 2025?
ResMed annual free cash flow for 2025 was $1.66B, a 27.65% increase from 2024.
What was ResMed's free cash flow in 2024?
ResMed annual free cash flow for 2024 was $1.30B, a 126.94% increase from 2023.
What is ResMed's 5-year free cash flow CAGR?
ResMed free cash flow grew at a compound annual growth rate (CAGR) of 21.07% from FY2021 to FY2026, going from $634.0M to $1.65B over 5 years.
- Company
- ResMed
- Ticker
- RMD
- Sector
- Healthcare
- Industry
- Surgical & Medical Instruments & Apparatus